Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions

K. Moghissi, K. Dixon, A. C. Thorpe, C. Oxtoby (Goole, United Kingdom)

Source: Annual Congress 2004 - New developments in endobronchial treatment
Session: New developments in endobronchial treatment
Session type: Oral Presentation
Number: 4292
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Objective: to investigate the efficacy and long term results of PDT in a subset of patients with lung cancer with disease limited to bronchial wall and lumen.
Material & Methods: 16 patients amongst 207 undergoing bronchoscopic PDT for lung cancer. All patients had standard investigation, work up and staging procedure as well as assessment of bronchoscopic extent of the endoluminal lesion. PDT method was intravenous injection of 2mg/kg/bw of Photofrin followed 24-72 hours later by bronchoscopic illumination for 150-200 joules/cm. Results were assessed by review and bronchoscopy at 5-6 weeks post PDT and at regular intervals in follow up clinic until death.
Results:16 subjects (10 male 6 female) aged 53-74 (mean 65.2) received 26 treatments. 7 patients had previous treatment (including 3 resections) with curative intent. In these PDT was given for local recurrence. There was no operative mortality. 1 patient developed mild skin photosensitivity. Every patient had a period of complete response 6-24 months. 7 patients have died. Their survival was from 2-103 months (mean 55.9). 9 are alive from 6-36 months (mean 21.6). Mean & median survival for the whole group was 64 ± 10 m & 77 ± 9 m respectively.
Conclusion: Bronchoscopic PDT appears to be an effective therapeutic method in patients with cancer limited to endobronchial lesions. In this subset long survival can be expected provided there is no extra bronchial dissemination.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Moghissi, K. Dixon, A. C. Thorpe, C. Oxtoby (Goole, United Kingdom). Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions. Eur Respir J 2004; 24: Suppl. 48, 4292

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Eur Respir J 2006; 28: 200-218
Year: 2006



Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003



Regional laser centre experience in bronchoscopic photodynamic therapy (PDT) in inoperable bronchopulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002

Photodynamic therapy (PDT) for in-situ (CIS) and micro-invasive (MCI) lungs cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004

Follow-up using fluorescence bronchoscopy for the patients with photodynamic therapy treated early lung cancer
Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy
Year: 2012


Endobronchial brachytherapy in the treatment of malignant lung tumours
Source: Eur Respir J 2004; 24: 348-352
Year: 2004



Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial).
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Annual Congress 2011 - PG1 Interventional pulmonology
Year: 2011



Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC
Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology
Year: 2012

Photodynamic therapy for endoscopically early hilar lung cancer using diode laser and talaporfin sodium (laserphyrin)
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Endobronchial photodynamic therapy with chlorine E6 in III-IV stage central lung cancer
Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy
Year: 2011

Endoscopical laser treatment in combined therapy non small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002

Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006

Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Long term assessment of photodynamic therapy for superficial bronchial cancer
Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Year: 2019

Combined radiation therapy in treatment of tracheal cancers
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Endoscopic photodynamic therapy with e6 chlorine in advanced stage lung cancer: Preliminary results
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010


A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC)
Source: Annual Congress 2009 - Biopsy techniques
Year: 2009


Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009